CCG
ZBH icon

Cypress Capital Group’s Zimmer Biomet ZBH Stock Holding History

Cypress Capital Group’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,719
Closed -$227K – 307
2024
Q1 		$227K Sell
1,719
-20
-1% -$2.5K 0.03% 278
2023
Q4 		$212K Sell
1,739
-99
-5% -$11K 0.03% 288
2023
Q3 		$206K Hold
1,838
– – 0.03% 288
2023
Q2 		$268K Hold
1,838
– – 0.04% 266
2023
Q1 		$237K Buy
+1,838
New +$231K 0.04% 265
2016
Q4 		– Sell
-2,266
Closed -$286K – 194
2016
Q3 		$286K Buy
+2,266
New +$280K 0.07% 154

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cypress Capital Group's ZBH Position: Q2 2024 in Review

Cypress Capital Group sold out of Zimmer Biomet (ZBH) in Q2 2024, closing a stake of 1,719 shares — an estimated $227K sold.

Cypress Capital Group first reported a position in ZBH in Q3 2016 and held it in 6 quarters. The position peaked at $286K in Q3 2016. 1,005 funds tracked by Wall St. Rank hold ZBH as of Q2 2024.

  • Cypress Capital Group reported no remaining Zimmer Biomet position as of Q2 2024 after selling out during the quarter.
  • Cypress Capital Group sold 1,719 Zimmer Biomet shares in Q2 2024, an estimated $227K.
  • Cypress Capital Group first reported a position in Zimmer Biomet in Q3 2016 and held it in 6 quarters.
  • Cypress Capital Group's Zimmer Biomet position peaked at $286K in Q3 2016.
  • 1,005 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2024.

Based on Cypress Capital Group's 13F filing for Q2 2024, filed 25 Jul 2024.